Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Candriam S.C.A.

Candriam S.C.A. trimmed its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 80.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,268 shares of the real estate investment trust's stock after selling 84,221 shares during the period. Candriam S.C.A.'s holdings in Sabra Health Care REIT were worth $351,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in SBRA. Geode Capital Management LLC grew its position in Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust's stock valued at $117,165,000 after buying an additional 104,533 shares during the period. JPMorgan Chase & Co. grew its position in shares of Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock valued at $183,996,000 after acquiring an additional 6,819,919 shares during the period. Vestcor Inc increased its stake in shares of Sabra Health Care REIT by 62.5% in the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust's stock worth $3,869,000 after purchasing an additional 79,956 shares in the last quarter. Barclays PLC increased its stake in shares of Sabra Health Care REIT by 56.1% in the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock worth $12,624,000 after purchasing an additional 243,895 shares in the last quarter. Finally, Franklin Resources Inc. raised its holdings in Sabra Health Care REIT by 12.3% in the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust's stock worth $9,543,000 after purchasing an additional 57,551 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Truist Financial cut Sabra Health Care REIT from a "buy" rating to a "hold" rating and lowered their price objective for the company from $18.00 to $17.00 in a research report on Friday, January 17th. JMP Securities raised shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a report on Tuesday, January 7th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. Finally, Mizuho restated a "neutral" rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.17.

Sabra Health Care REIT Price Performance

Shares of SBRA stock traded up $0.44 during mid-day trading on Friday, hitting $17.30. The company had a trading volume of 2,344,467 shares, compared to its average volume of 2,168,165. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock's 50 day moving average price is $16.73 and its 200-day moving average price is $17.65. Sabra Health Care REIT, Inc. has a 52-week low of $13.31 and a 52-week high of $20.03. The company has a market capitalization of $4.12 billion, a P/E ratio of 32.64, a P/E/G ratio of 1.97 and a beta of 1.27.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.94%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 226.42%.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.